Vertex Pharmaceuticals Inc. buy UBS Group AG
Start price
07.11.25
/
50%
€352.60
Target price
07.11.26
€473.22
Performance (%)
1.04%
Price
16:06
€356.25
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 1.04%. This prediction currently runs until 07.11.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Vertex Pharmaceuticals Inc. | 1.04% |
| iShares Core DAX® | -0.917% |
| iShares Nasdaq 100 | -3.301% |
| iShares Nikkei 225® | -4.194% |
| iShares S&P 500 | -1.866% |
Comments by UBS_Group_AG for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target lowered by analysts at UBS Group AG from $553.00 to $546.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€344.35
05.08.25
05.08.25
€478.40
05.08.26
05.08.26
3.46%
16:06
16:06
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.85
05.11.24
05.11.24
€536.01
05.11.25
05.11.25
-21.69%
06.11.25
06.11.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.95
17.10.24
17.10.24
€519.06
17.10.25
17.10.25
-21.84%
18.10.25
18.10.25